Relevant bibliographies by topics / Therapeutically / Journal articles

Journal articles on the topic 'Therapeutically'

To see the other types of publications on this topic, follow the link: Therapeutically.
Author: Grafiati
Published: 10 December 2022
Last updated: 29 January 2023

Create a spot-on reference in APA, MLA, Chicago, Harvard, and other styles

Select a source type:

Consult the top 50 journal articles for your research on the topic 'Therapeutically.'

Next to every source in the list of references, there is an 'Add to bibliography' button. Press on it, and we will generate automatically the bibliographic reference to the chosen work in the citation style you need: APA, MLA, Harvard, Chicago, Vancouver, etc.

You can also download the full text of the academic publication as pdf and read online its abstract whenever available in the metadata.

Browse journal articles on a wide variety of disciplines and organise your bibliography correctly.

1

Reichelt, Bernd. "„… therapeutisch besonders wirksam.“." Medizinhistorisches Journal 56, no. 1-2 (2021): 58. http://dx.doi.org/10.25162/mhj-2021-0003.

Full text
APA, Harvard, Vancouver, ISO, and other styles
2

Wexler, David B. "Applying the law therapeutically." Applied and Preventive Psychology 5, no. 3 (June 1996): 179–86. http://dx.doi.org/10.1016/s0962-1849(96)80010-2.

Full text
APA, Harvard, Vancouver, ISO, and other styles
3

Epstein, Richard J. "TNM: Therapeutically Not Mandatory." European Journal of Cancer 45, no. 7 (May 2009): 1111–16. http://dx.doi.org/10.1016/j.ejca.2009.02.020.

Full text
APA, Harvard, Vancouver, ISO, and other styles
4

Stein, Richard A. "Think Epigenetically, Act Therapeutically." Genetic Engineering & Biotechnology News 35, no. 2 (January 15, 2015): 1, 16, 18–19. http://dx.doi.org/10.1089/gen.35.02.02.

Full text
APA, Harvard, Vancouver, ISO, and other styles
5

Azevedo, Nadia Pereira da Silva Gonçalves de, and Jônia Alves Lucena. "Perspectiva linguístico-discursiva na terapêutica da gagueira." Cadernos de Estudos Lingüísticos 51, no. 2 (July 14, 2011): 167–86. http://dx.doi.org/10.20396/cel.v51i2.8637210.

Full text
Abstract:
Endorsed in the theoretical estimates by the Analysis of the The French Discourse Analysis, that defines the person as social and marked ideologically, we analyze the therapeutical process of stuttering subjects from the perspective of that discourse linguistics conception. Under this view, we discuss Speech Therapeutic works that take stuttering as a manifestation of the body, involving muscular tension, breath, production of speech, genetics, in sum, an “illness”. We review Speech Therapeutic quarrels about stuttering, and launch a new view, from the discourse linguistics perspective, with therapeutically possibilities for these stuttering subjects. We analyze the speech clippings from the speech analysis of two stuttering subjects in process of Speech Therapeutic attendance, in a longitudinal form. We assume, thus, stuttering as a language matter, directly related to the production conditions, with therapeutically possibilities under the same perspective.
APA, Harvard, Vancouver, ISO, and other styles
6

Jain, AnilK, Prashant Modi, Ravi Sreenivasan, IshK Dhammi, Jaswant Kumar, and NamitaSingh Saini. "Tuberculosis spine: Therapeutically refractory disease." Indian Journal of Orthopaedics 46, no. 2 (2012): 171. http://dx.doi.org/10.4103/0019-5413.93685.

Full text
APA, Harvard, Vancouver, ISO, and other styles
7

Discenza, Deborah. "Helping Babies Therapeutically Post-NICU." Neonatal Network 31, no. 5 (2012): 339–40. http://dx.doi.org/10.1891/0730-0832.31.5.339.

Full text
APA, Harvard, Vancouver, ISO, and other styles
8

Abreu, Paula A., Cid A. Medeiros, Julio C. Borges, Alice M. R. Bernardino, Carlos R. Rodrigues, and Helena C. Castro. "Tuberculosis: a therapeutically neglected disease." Current Drug Therapy 999, no. 999 (July 1, 2013): 1–6. http://dx.doi.org/10.2174/15748855113089990006.

Full text
APA, Harvard, Vancouver, ISO, and other styles
9

Bentley, Jennifer. "Helping to ease pain therapeutically." Nursing Standard 5, no. 46 (August 7, 1991): 33. http://dx.doi.org/10.7748/ns.5.46.33.s39.

Full text
APA, Harvard, Vancouver, ISO, and other styles
10

Corrie, Sarah. "Working Therapeutically with Adult Stepchildren." Journal of Divorce & Remarriage 37, no. 1-2 (August 2002): 135–50. http://dx.doi.org/10.1300/j087v37n01_08.

Full text
APA, Harvard, Vancouver, ISO, and other styles
11

Illfelder-Kaye, Joyce. "Treating the College Student Therapeutically." Contemporary Psychology: A Journal of Reviews 32, no. 7 (July 1987): 674. http://dx.doi.org/10.1037/027353.

Full text
APA, Harvard, Vancouver, ISO, and other styles
12

DeJongste, M. J. L. "Chronic therapeutically refractory angina pectoris." Heart 90, no. 2 (February 1, 2004): 225–30. http://dx.doi.org/10.1136/hrt.2003.025031.

Full text
APA, Harvard, Vancouver, ISO, and other styles
13

Bowne, Douglas. "How to Use Equipment Therapeutically." Journal of Experiential Education 9, no. 3 (November 1986): 16–19. http://dx.doi.org/10.1177/105382598600900304.

Full text
APA, Harvard, Vancouver, ISO, and other styles
14

Attar, Eyal C. "Therapeutically targeting leukemia stem cells." Blood 106, no. 13 (December 15, 2005): 4021–22. http://dx.doi.org/10.1182/blood-2005-09-3853.

Full text
APA, Harvard, Vancouver, ISO, and other styles
15

Rek, A., E. Krenn, and AJ Kungl. "Therapeutically targeting protein-glycan interactions." British Journal of Pharmacology 157, no. 5 (July 2009): 686–94. http://dx.doi.org/10.1111/j.1476-5381.2009.00226.x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
16

Heck, K., T. Chow, M. Mawad, and J. C. Goodman. "HISTOPATHOLOGY OF THERAPEUTICALLY EMBOLIZED MENINGIOMAS." Journal of Neuropathology and Experimental Neurology 52, no. 3 (May 1993): 269. http://dx.doi.org/10.1097/00005072-199305000-00036.

Full text
APA, Harvard, Vancouver, ISO, and other styles
17

Bogdan, Constantin, and Laurenţiu Bogdan. "Psychological changes and psychiatric disorders in case of terminally ill patients." Romanian Medical Journal 62, no. 3 (September 30, 2015): 249–54. http://dx.doi.org/10.37897/rmj.2015.3.6.

Full text
Abstract:
The terminal stages that come prior to the exitus – in incurable diseases, „fin de vie des vieux“ – are characterised, among others, by a number of psychological changes and psychiatric disorders that need to be diagnosed and therapeutically tackled through psycho-therapy and appropriate medication, in order to improve the quality of life. International research in this field and also own observations of the authors of the study on the structure of the entities that can be found and their order frequency are presented in the paper. Among the most frequent are the following: anxiety, depression, delirium, suicidal risk, cognitive disorders that are detailed according to intensity, evolution, therapeutical response. Anxiety occurs as a result of awareness of the proximity of the death. Management of the depression includes antidepressant medication and, especially, supportive psychoterapy. With reference to the suicidal risk, a careful assesment of the risk must be done. Cognitive disorders are more serious and difficult to be influenced therapeutically.
APA, Harvard, Vancouver, ISO, and other styles
18

Ibrahim, Ahmed G. E., Chang Li, Russel Rogers, Mario Fournier, Liang Li, Sharon D. Vaturi, Travis Antes, et al. "Augmenting canonical Wnt signalling in therapeutically inert cells converts them into therapeutically potent exosome factories." Nature Biomedical Engineering 3, no. 9 (August 26, 2019): 695–705. http://dx.doi.org/10.1038/s41551-019-0448-6.

Full text
APA, Harvard, Vancouver, ISO, and other styles
19

Varalakshmi S, Varalakshmi S. "Comparative analysis of antibacterial activity of two therapeutically active plants." International Journal of Scientific Research 3, no. 6 (June 1, 2012): 403–4. http://dx.doi.org/10.15373/22778179/june2014/135.

Full text
APA, Harvard, Vancouver, ISO, and other styles
20

Ferris, Katy, James Marson, and Anna Kawalek. "Applying Refugee Family Reunion Law Therapeutically." Beijing Law Review 10, no. 05 (2019): 1172–96. http://dx.doi.org/10.4236/blr.2019.105062.

Full text
APA, Harvard, Vancouver, ISO, and other styles
21

Radenkovic, Dina, Reason, and Eric Verdin. "Clinical Evidence for Targeting NAD Therapeutically." Pharmaceuticals 13, no. 9 (September 15, 2020): 247. http://dx.doi.org/10.3390/ph13090247.

Full text
Abstract:
Nicotinamide adenine dinucleotide (NAD) pharmacology is a promising class of treatments for age-related conditions that are likely to have a favorable side effect profile for human use, given the widespread use of the NAD precursor vitamin B3 supplements. However, despite several decades of active investigation and numerous possible biochemical mechanisms of action suggested, only a small number of randomized and adequately powered clinical trials of NAD upregulation as a therapeutic strategy have taken place. We conducted a systematic review of the literature, following the PRISMA guidelines, in an attempt to determine whether or not the human clinical trials performed to date support the potential benefits of NAD supplementation in a range of skin, metabolic and age-related conditions. In addition, we sought medical indications that have yielded the most promising results in the limited studies to date. We conclude that promising, yet still speculative, results have been reported for the treatment of psoriasis and enhancement of skeletal muscle activity. However, further trials are required to determine the optimal method of raising NAD levels, identifying the target conditions, and comparisons to the present standard of care for these conditions. Lastly, pharmacological methods that increase NAD levels should also be directly compared to physiological means of raising NAD levels, such as exercise programs and dietary interventions that are tailored to older individuals, and which may be more effective.
APA, Harvard, Vancouver, ISO, and other styles
22

Drakaki, Alexandra, Maria Hatziapostolou, and Dimitrios Iliopoulos. "Therapeutically Targeting MicroRNAs in Liver Cancer." Current Pharmaceutical Design 19, no. 7 (December 1, 2012): 1180–91. http://dx.doi.org/10.2174/1381612811319070002.

Full text
APA, Harvard, Vancouver, ISO, and other styles
23

Garris, Christopher, and Mikael J. Pittet. "Therapeutically reeducating macrophages to treat GBM." Nature Medicine 19, no. 10 (October 2013): 1207–8. http://dx.doi.org/10.1038/nm.3355.

Full text
APA, Harvard, Vancouver, ISO, and other styles
24

Singletary, Jamil, Patricia A. Wood, Jovelyn Du-Quiton, Song Wang, Xiaoming Yang, Shobhit Vishnoi, and William J. M. Hrushesky. "Imaging Multidimensional Therapeutically Relevant Circadian Relationships." International Journal of Biomedical Imaging 2009 (2009): 1–8. http://dx.doi.org/10.1155/2009/231539.

Full text
Abstract:
Circadian clocks gate cellular proliferation and, thereby, therapeutically target availability within proliferative pathways. This temporal coordination occurs within both cancerous and noncancerous proliferating tissues. The timing within the circadian cycle of the administration of drugs targeting proliferative pathways necessarily impacts the amount of damage done to proliferating tissues and cancers. Concurrently measuring target levels and associated key pathway components in normal and malignant tissues around the circadian clock provides a path toward a fuller understanding of the temporal relationships among the physiologic processes governing the therapeutic index of antiproliferative anticancer therapies. The temporal ordering among these relationships, paramount to determining causation, is less well understood using two- or three-dimensional representations. We have created multidimensional multimedia depictions of the temporal unfolding of putatively causative and the resultant therapeutic effects of a drug that specifically targets these ordered processes at specific times of the day. The systems and methods used to create these depictions are provided, as well as three example supplementary movies.
APA, Harvard, Vancouver, ISO, and other styles
25

Maxson, Julia E., Monika A. Davare, Samuel B. Luty, Christopher A. Eide, Bill H. Chang, Marc M. Loriaux, Cristina E. Tognon, et al. "Therapeutically Targetable ALK Mutations in Leukemia." Cancer Research 75, no. 11 (May 31, 2015): 2146–50. http://dx.doi.org/10.1158/0008-5472.can-14-1576.

Full text
APA, Harvard, Vancouver, ISO, and other styles
26

Puylaert, Martine. "Pelvic Pain: Mechanistically Enigmatic, Therapeutically Challenging." Pain Practice 13, no. 1 (December 13, 2012): 1–2. http://dx.doi.org/10.1111/papr.12019.

Full text
APA, Harvard, Vancouver, ISO, and other styles
27

Heinegg, Peter. "Religiously Flavored Therapy, Therapeutically Flavored Morality." CrossCurrents 67, no. 2 (June 2017): 486–88. http://dx.doi.org/10.1111/cros.12260.

Full text
APA, Harvard, Vancouver, ISO, and other styles
28

Drakaki, Alexandra, Maria Hatziapostolou, and Dimitrios Iliopoulos. "Therapeutically Targeting MicroRNAs in Liver Cancer." Current Pharmaceutical Design 19, no. 7 (December 10, 2012): 1180–91. http://dx.doi.org/10.2174/138161213804805658.

Full text
APA, Harvard, Vancouver, ISO, and other styles
29

Kumari, Avnesh, and Sudesh Kumar Yadav. "Cellular interactions of therapeutically delivered nanoparticles." Expert Opinion on Drug Delivery 8, no. 2 (January 11, 2011): 141–51. http://dx.doi.org/10.1517/17425247.2011.547934.

Full text
APA, Harvard, Vancouver, ISO, and other styles
30

Hewitt, Sandra K. "Therapeutically Managing Reunification After Abuse Allegations." Journal of Child Sexual Abuse 17, no. 1 (April 4, 2008): 17–19. http://dx.doi.org/10.1080/10538710701884326.

Full text
APA, Harvard, Vancouver, ISO, and other styles
31

Levin, Jeffrey S., and Harold Y. Vanderpool. "Is religion therapeutically significant for hypertension?" Social Science & Medicine 29, no. 1 (January 1989): 69–78. http://dx.doi.org/10.1016/0277-9536(89)90129-9.

Full text
APA, Harvard, Vancouver, ISO, and other styles
32

McMillan, R. M., and E. R. H. Walker. "Designing therapeutically effective 5-lipoxygenase inhibitors." Trends in Pharmacological Sciences 13 (January 1992): 323–30. http://dx.doi.org/10.1016/0165-6147(92)90100-k.

Full text
APA, Harvard, Vancouver, ISO, and other styles
33

Datta, Pooja, and Stacy A. Ogbeide. "Working Therapeutically With Patients With Kidney Disease." Journal of Health Service Psychology 47, no. 2 (April 23, 2021): 95–104. http://dx.doi.org/10.1007/s42843-021-00036-3.

Full text
APA, Harvard, Vancouver, ISO, and other styles
34

Ocon, Anthony, Sravani Lokineni, and Benjamin Korman. "Understanding and Therapeutically Targeting the Scleroderma Myofibroblast." Current Treatment Options in Rheumatology 8, no. 1 (March 2022): 1–18. http://dx.doi.org/10.1007/s40674-021-00189-8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
35

Tamura, Tetsuya, Gail Otulakowski, and Brian P. Kavanagh. "Could nanotechnology make vitamin E therapeutically effective?" American Journal of Physiology-Lung Cellular and Molecular Physiology 316, no. 1 (January 1, 2019): L1—L5. http://dx.doi.org/10.1152/ajplung.00430.2018.

Full text
Abstract:
Vitamin E (VitE) has important antioxidant and anti-inflammatory effects and is necessary for normal physiological function. α-Tocopherol (α-T), the predominant form of VitE in human tissues, has been extensively studied. Other VitE forms, particularly γ-tocopherol (γ-T), are also potent bioactive molecules. The effects are complex, involving both reactive oxygen and nitrogen species, but trials of VitE have been generally negative. We propose that a nanoparticle approach to delivery of VitE might provide effective delivery and therapeutic effect.
APA, Harvard, Vancouver, ISO, and other styles
36

Martin, Jennifer H., and Noel Cranswick. "Care and concern with cannabinoids used therapeutically." British Journal of Clinical Pharmacology 84, no. 11 (August 22, 2018): 2455–57. http://dx.doi.org/10.1111/bcp.13724.

Full text
APA, Harvard, Vancouver, ISO, and other styles
37

Ellegård, Rada, Esaki M. Shankar, and Marie Larsson. "Targeting HIV-1 innate immune responses therapeutically." Current Opinion in HIV and AIDS 6, no. 5 (September 2011): 435–43. http://dx.doi.org/10.1097/coh.0b013e32834970d8.

Full text
APA, Harvard, Vancouver, ISO, and other styles
38

Hammerschmidt, Dale E. "Can albumin size differences be exploited therapeutically?" Journal of Laboratory and Clinical Medicine 143, no. 2 (February 2004): 73. http://dx.doi.org/10.1016/j.lab.2003.12.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
39

Fernández, Ariel. "Deep Learning to Therapeutically Target Unreported Complexes." Trends in Pharmacological Sciences 40, no. 8 (August 2019): 551–54. http://dx.doi.org/10.1016/j.tips.2019.04.009.

Full text
APA, Harvard, Vancouver, ISO, and other styles
40

Carai, Mauro A. M., Giancarlo Colombo, and Gian Luigi Gessa. "Rimonabant: The first therapeutically relevant cannabinoid antagonist." Life Sciences 77, no. 19 (September 2005): 2339–50. http://dx.doi.org/10.1016/j.lfs.2005.04.017.

Full text
APA, Harvard, Vancouver, ISO, and other styles
41

Dressler, Dirk. "Therapeutically relevant features of botulinum toxin drugs." Toxicon 175 (February 2020): 64–68. http://dx.doi.org/10.1016/j.toxicon.2019.12.005.

Full text
APA, Harvard, Vancouver, ISO, and other styles
42

Revoltella, Roberto P. "Natural and therapeutically-induced antibodies to cytokines." Biotherapy 10, no. 4 (December 1998): 321–31. http://dx.doi.org/10.1007/bf02678552.

Full text
APA, Harvard, Vancouver, ISO, and other styles
43

Vieth, Michal, Jeffrey J. Sutherland, Daniel H. Robertson, and Robert M. Campbell. "Kinomics: characterizing the therapeutically validated kinase space." Drug Discovery Today 10, no. 12 (June 2005): 839–46. http://dx.doi.org/10.1016/s1359-6446(05)03477-x.

Full text
APA, Harvard, Vancouver, ISO, and other styles
44

Spaulding, Stephen W. "Can Thyroid Hormone Metabolites Be Exploited Therapeutically?" Clinical Thyroidology 26, no. 5 (May 2014): 123–25. http://dx.doi.org/10.1089/ct.2014;26.123-125.

Full text
APA, Harvard, Vancouver, ISO, and other styles
45

Graci, Jason D., and Craig E. Cameron. "Therapeutically targeting RNA viruses via lethal mutagenesis." Future Virology 3, no. 6 (November 2008): 553–66. http://dx.doi.org/10.2217/17460794.3.6.553.

Full text
APA, Harvard, Vancouver, ISO, and other styles
46

Welbom, Michelle Warren, and Julie F. Connelly. "Are Proventil Repetabs and Volmax therapeutically equivalent?" American Journal of Health-System Pharmacy 52, no. 8 (April 15, 1995): 798–802. http://dx.doi.org/10.1093/ajhp/52.8.798.

Full text
APA, Harvard, Vancouver, ISO, and other styles
47

Wani, Snober Shabeer, Parvaiz A. Dar, Sajad M. Zargar, and Tanveer A. Dar. "Therapeutic Potential of Medicinal Plant Proteins: Present Status and Future Perspectives." Current Protein & Peptide Science 21, no. 5 (June 2, 2020): 443–87. http://dx.doi.org/10.2174/1389203720666191119095624.

Full text
Abstract:
Biologically active molecules obtained from plant sources, mostly including secondary metabolites, have been considered to be of immense value with respect to the treatment of various human diseases. However, some inevitable limitations associated with these secondary metabolites like high cytotoxicity, low bioavailability, poor absorption, low abundance, improper metabolism, etc., have forced the scientific community to explore medicinal plants for alternate biologically active molecules. In this context, therapeutically active proteins/peptides from medicinal plants have been promoted as a promising therapeutic intervention for various human diseases. A large number of proteins isolated from the medicinal plants have been shown to exhibit anti-microbial, anti-oxidant, anti-HIV, anticancerous, ribosome-inactivating and neuro-modulatory activities. Moreover, with advanced technological developments in the medicinal plant research, medicinal plant proteins such as Bowman-Birk protease inhibitor and Mistletoe Lectin-I are presently under clinical trials against prostate cancer, oral carcinomas and malignant melanoma. Despite these developments and proteins being potential drug candidates, to date, not a single systematic review article has documented the therapeutical potential of the available biologically active medicinal plant proteome. The present article was therefore designed to describe the current status of the therapeutically active medicinal plant proteins/peptides vis-à-vis their potential as future protein-based drugs for various human diseases. Future insights in this direction have also been highlighted.
APA, Harvard, Vancouver, ISO, and other styles
48

Zvěřina, Jaroslav, Petr Weiss, and Martin Hollý. "Results of therapeutically castration by paraphiliac sexual offenders." Psychiatrie pro praxi 17, no. 1 (March 1, 2016): 15–17. http://dx.doi.org/10.36290/psy.2016.004.

Full text
APA, Harvard, Vancouver, ISO, and other styles
49

Ciurea, Marius, Ada Georgescu, Stefana Purcaru, Stefan-Alexandru Artene, Ghazaleh Emami, Mihai Boldeanu, Daniela Tache, and Anica Dricu. "Cancer Stem Cells: Biological Functions and Therapeutically Targeting." International Journal of Molecular Sciences 15, no. 5 (May 9, 2014): 8169–85. http://dx.doi.org/10.3390/ijms15058169.

Full text
APA, Harvard, Vancouver, ISO, and other styles
50

Hill, LaQuisa C., and Premal D. Lulla. "COVID-specific T's may offset therapeutically endangered B's." Blood 139, no. 1 (January 6, 2022): 12–13. http://dx.doi.org/10.1182/blood.2021014466.

Full text
APA, Harvard, Vancouver, ISO, and other styles
You might also be interested in the bibliographies on the topic 'Therapeutically' for other source types:
Dissertations / Theses Books
We offer discounts on all premium plans for authors whose works are included in thematic literature selections. Contact us to get a unique promo code!

To the bibliography